China Biotech Services Holdings Limited (8037.HK) HKSE

0.97

+0.01(+1.04%)

Updated at October 20 09:33AM

Currency In HKD

Valuation

Market Cap493.93M
Enterprise Value662.85M
P/E Ratio-6.23
PEG Ratio-0.37
Price/Sales Ratio12.15
Price/Book Ratio3.92
Enterprise/Revenue14.78
Enterprise/EBITDA-17.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.95
Operating Margin-0.49

Management Effectiveness

Return On Assets-0.28
Return On Equity-0.6

Income Statement

Revenue70.51M
Revenue/Share0.08
Gross Profit-4.94M
EBITDA-101.07M
Net Income-198.15M
Diluted EPS-0.2

Balance Sheet

Total Cash11.29M
Total Cash/Share0.01
Total Debt213.43M
Total Debt/Equity0.89
Current Ratio0.18
Book Value Per Share0.22

Price History

52-Week Change220
52-Week High1.33
52-Week Low0.28
Moving Average 50 Days0.96
Moving Average 200 Days0.65

Statistics

Average Volume1.3M
Shares Outstanding973.82M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:2
Last Split DateMarch 08, 2016